Business Description
Kwality Pharmaceuticals Ltd
ISIN : INE552U01010
Total Employee Number:
997Description
Kwality Pharmaceuticals Ltd is engaged in the business of manufacturing and trading in pharmaceuticals and allied products. It is an integrated pharmaceutical company involved in the development, manufacturing and marketing of a diversified range of pharmaceutical formulations catering to regulated, semi-regulated and emerging markets. The Company manufactures, buys, sells and deals in all kinds of drug intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. Its products include Injectables, Tablets, Capsules, Liquid Orals & Externals and others.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.39 | |||||
Debt-to-EBITDA | 0.95 | |||||
Interest Coverage | 10.58 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 10.89 | |||||
Beneish M-Score | -1.45 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26.1 | |||||
3-Year EBITDA Growth Rate | 37.2 | |||||
3-Year EPS without NRI Growth Rate | 28.5 | |||||
3-Year FCF Growth Rate | -72.6 | |||||
3-Year Book Growth Rate | 18.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.8 | |||||
Quick Ratio | 1.45 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 103.8 | |||||
Days Sales Outstanding | 131.31 | |||||
Days Payable | 91.21 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 48.04 | |||||
Operating Margin % | 20.77 | |||||
Net Margin % | 14.63 | |||||
EBITDA Margin % | 24.8 | |||||
FCF Margin % | -5.84 | |||||
OCF Margin % | 2.99 | |||||
ROE % | 27.45 | |||||
ROA % | 16.03 | |||||
ROIC % | 21.39 | |||||
3-Year ROIIC % | 22.69 | |||||
ROC (Joel Greenblatt) % | 30.67 | |||||
ROCE % | 36.99 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 46.49 | |||||
PE Ratio without NRI | 46.15 | |||||
Shiller PE Ratio | 100.67 | |||||
PEG Ratio | 3.1 | |||||
PS Ratio | 6.8 | |||||
PB Ratio | 11.36 | |||||
Price-to-Tangible-Book | 11.56 | |||||
Price-to-Operating-Cash-Flow | 227.12 | |||||
EV-to-EBIT | 33.13 | |||||
EV-to-EBITDA | 28.3 | |||||
EV-to-Revenue | 7.01 | |||||
EV-to-FCF | -114.6 | |||||
Price-to-GF-Value | 2.73 | |||||
Price-to-Projected-FCF | 14.63 | |||||
| Price-to-Net-Current-Asset-Value | 25.97 | |||||
Earnings Yield (Greenblatt) % | 3.01 | |||||
FCF Yield % | -0.86 | |||||
Forward Rate of Return (Yacktman) % | 14.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kwality Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 5,539.565 | ||
| EPS (TTM) (₹) | 78.1 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (₹) | - | ||
| 20-Day SMA (₹) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 3436.5 - 3708.9 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kwality Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kwality Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kwality Pharmaceuticals Ltd Frequently Asked Questions
What is Kwality Pharmaceuticals Ltd(NSE:KPL)'s stock price today?
The current price of NSE:KPL is ₹3630.30. The 52 week high of NSE:KPL is ₹3708.90 and 52 week low is ₹3436.50.
When is next earnings date of Kwality Pharmaceuticals Ltd(NSE:KPL)?
The next earnings date of Kwality Pharmaceuticals Ltd(NSE:KPL) is .
Does Kwality Pharmaceuticals Ltd(NSE:KPL) pay dividends? If so, how much?
Kwality Pharmaceuticals Ltd(NSE:KPL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kwality Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers